Biotechnology valuation An Introductory Guide Karl Keegan Written by experienced financial analyst, Karl Keegan, Biotechnology Valuation: An Introductory Guide is a hands–on guide to the valuation of biotechnology companies both from a private and public market perspective for industry professionals, investors and students. Focused on product based biotechnology investments and drawing on the author’s extensive experience the book begins by valuing healthcare focussed biotechnology companies which are trying to develop new therapeutics using traditional valuation metrics for those readers unfamiliar with finance. The book then takes these principles and applies them to the unique aspects of biotechnology valuation. A background guide to the intricacies of drug development is provided including descriptions of the different clinical phases, relevant regulatory pathways and the attributes that contribute to make a successful drug. The financial analysis and...

Под заказ:
	OZON.ru - 4988 руб.	Перейти

Рейтинг книги: 5 из 5, 8 голос(-ов).